News
Advertisement
Advertisement
Advertisement
With issues surrounding COVID-19, the cornoavirus, grabbing headlines across the country and around the globe, ophthalmologists must understand the risks to be informed and positioned to provide quality care for their patients.
Delivering the Drs. Henry and Frederick Sutro Memorial Lecture, David W. Parke II, MD, CEO of the American Academy of Ophthalmology, points out that patients and physicians can benefit from innovations in treatment. However, health policy and economics often can stand in the way of innovation.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA issues Complete Response Letter to Sydnexis for SYD-101 pediatric myopia treatment
2
Nanoscope Therapeutics releases positive 3-year follow-up data from REMAIN study
3
Proactive strategies and sustained delivery advance glaucoma care
4
STAAR postpones Alcon merger vote, Broadwood calls for removal of board members
5
.png "Optometry Times"){kind=logo}
